Transplant News and Research

RSS

Positive data from Chimerix CMX001 Phase 2 study on CMV disease

Chimerix, Inc., a biotechnology company developing novel antiviral therapeutics, today announced positive results from CMX001 Study 201, a Phase 2 study evaluating CMX001 for the prevention of cytomegalovirus (CMV) disease in hematopoietic stem cell transplant (HCT) recipients.

6 Feb 2012

Successful six organ transplants in 9 year old

A 9 year old girl from Maine is making recovery days after surgeons transplanted six of her organs in a groundbreaking medical procedure.

6 Feb 2012

Positive results from Chimerix CMX001 study for CMV in hematopoietic stem cell transplant recipients

6 Feb 2012

U-M develops new system to reduce incidence of retained surgical instruments

It may sound like something from a TV medical drama, but the incidence of surgeons leaving something behind in the body is very real at hospitals across the country. For decades, surgical teams have relied on counting -- and recounting -- the sponges, needles, blades, retractors, and other items used during operations.

6 Feb 2012

AOPO supports and facilitates living organ and tissue donation

Currently, there are more than 112,000 patients on the national organ transplant waiting list. These candidates often endure difficult yet necessary life-sustaining treatments while waiting for potential organ matches. Nineteen people die every day while waiting, and those that are eventually transplanted can endure wait times that can extend anywhere from 5-9 years.

6 Feb 2012

Tennessee Gov. declares February as 'St. Jude Month'

In 1962, St. Jude Children's Research Hospital opened its doors amid an emotionally charged debate regarding how to treat childhood cancer. At that time, few children with the most common form of childhood cancer survived, and many physicians believed treatment was futile. St. Jude physicians and researchers took a radically different approach, and these efforts proved pivotal in changing the way the world treats childhood cancer.

6 Feb 2012

Marin Magazine names Sutter Health physicians among [415] Top Doctors 2012

Almost 250 physicians at California Pacific Medical Center, Sutter Pacific Medical Foundation, and Novato Community Hospital - all part of the Sutter Health network - have been named on the prestigious list of [415] Top Doctors 2012 by Marin Magazine.

3 Feb 2012

Study examines link between blood pressure and risk of ESRD under 'real world' conditions

An upward revision of the blood pressure numbers used to identify risk of end-stage renal disease (ESRD) might actually help doctors provide better care for their patients, said the authors of a study in patients with chronic kidney disease.

3 Feb 2012

Immune cells from healthy individuals effectively kill cancer cells

Immune cells from healthy individuals can be the new immune cure for cancer. This treatment can kill cancer cells without destroying neighbouring cells. The hope is to eradicate cancer for ever.

3 Feb 2012

Healthy lung tissue transplantation shows promise for patients with pulmonary diseases

For patients suffering from severe pulmonary diseases including emphysema, lung cancer or fibrosis, transplantation of healthy lung tissue may offer the best chance for survival. The surgical procedure, however, faces two primary challenges: an acute shortage of donor lungs and rejection of transplanted tissue by the recipient's immune system.

2 Feb 2012

Ligand announces results from melphalan Phase II study on multiple myeloma

Ligand Pharmaceuticals Incorporated announced that results from the Phase II study of its Captisol-enabled, propylene glycol-free (PG-free) Melphalan program were featured this evening in a poster presentation at the combined annual meetings of the Center for International Blood & Marrow Transplant Research (CIBMTR) and the American Society for Blood and Marrow Transplantation (ASBMT) in San Diego.

2 Feb 2012

OPN-305 may improve survival outcomes for kidney transplant patients

New research published online in the FASEB Journal details a new antibody, called "OPN-305" that may significantly improve survival outcomes for those receiving donated kidneys and other organs.

1 Feb 2012

State roundup: Iowa reconsiders lawmakers' benefits

Two bills introduced in the Iowa House last week would curtail benefits for lawmakers. ... House File 2118 also removes per diem and daily allowances from inclusion in lawmakers' pension calculations, but also requires members and employees of the General Assembly to pay a portion of their health-insurance premiums. That premium payment would have to be at least $100 a month.

1 Feb 2012

Majority of children can safely quit anti-rejection drugs after liver transplant from parents

Physicians at three transplant centers have found in a pilot study that a majority of children who receive liver tissue from a parent can eventually stop using immunosuppression (anti-rejection) medications safely. These drugs, which tamp down natural immune function, have been linked to a bevy of complications, including cancer, diabetes, hypertension and kidney failure.

1 Feb 2012

CPET measurement predicts mortality in patients following liver transplantation

Researchers from the U.K. determined that preoperative cardiopulmonary exercise testing (CPET) is a specific predictor of 90-day survival following liver transplantation.

1 Feb 2012

Cardiopulmonary exercise testing may predict post-liver transplantation survival

Researchers from the U.K. determined that preoperative cardiopulmonary exercise testing (CPET) is a specific predictor of 90-day survival following liver transplantation. Study results available in the February issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases, shows that the CPET measurement—the anaerobic threshold or fitness level—significantly predicts mortality in patients post-transplantation.

31 Jan 2012

Non-smoking, non-drinking transplant patients more likely to develop head and neck cancer

Transplant patients who develop head and neck cancer are more likely to be non-smokers and non-drinkers, and less likely than their non-transplant counterparts to survive past one year of diagnosis, according to a new study from Henry Ford Hospital in Detroit.

30 Jan 2012